Syngen Biotech Co.,Ltd. (TPEX:8279)
Taiwan · Delayed Price · Currency is TWD 116.00
-0.50 (-0.43%)
Dec 31, 2025, 1:30 PM CST
Syngen Biotech Market Cap
Syngen Biotech has a market cap or net worth of 3.14 billion as of December 31, 2025. Its market cap has decreased by -11.45% in one year.
Market Cap
3.14B
Enterprise Value
3.14B
Revenue
2.13B
Ranking
n/a
PE Ratio
10.77
Stock Price
116.00
Market Cap Chart
Since November 2, 2004, Syngen Biotech's market cap has increased from 372.00M to 3.14B, an increase of 745.08%. That is a compound annual growth rate of 10.60%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Dec 31, 2025 | 3.14B | -8.66% |
| Dec 30, 2024 | 3.44B | -16.45% |
| Dec 29, 2023 | 4.12B | -6.17% |
| Dec 30, 2022 | 4.39B | 43.36% |
| Dec 30, 2021 | 3.06B | 4.63% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Caliway Biopharmaceuticals | 240.39B |
| PharmaEssentia | 173.83B |
| Lotus Pharmaceutical | 74.42B |
| Heron Neutron Medical | 70.65B |
| Bora Pharmaceuticals Co., LTD. | 60.52B |
| Lin BioScience | 32.84B |
| Lumosa Therapeutics | 32.77B |
| Center Laboratories | 31.06B |